Kerala-based Sabine Hospital Secures $50 Mn Funding from CX Partners

This investment aims to expand the hospital's fertility, birthing, and neonatal care services to make them more accessible and affordable.

Kerala-based Sabine Hospital and Research Centre has received $50 million in funding from private equity firm CX Partners. 

This investment aims to expand the hospital's fertility, birthing, and neonatal care services to make them more accessible and affordable.

Sabine Hospital, founded in 2010 by Dr Sivadasan, offers various services, including infertility treatment, assisted reproductive technology, obstetrics, gynecology, neonatology, pediatrics, general surgery, and genetics. 

The hospital operates 300 beds, including 60 NICU beds, across two facilities in Kerala. It conducts more than 6,000 IVF cycles and 3,000 deliveries annually, attracting patients from the Maldives, Oman, and Bangladesh and local patients from Kerala.

Commenting on the funding development, Dr Sivadasan Sabine, founder and chairman of Sabine Hospital, said, "The $50 million investment validates our strong clinical fundamentals and business practices and also recognizes the immense need for better fertility, motherhood, and child care in India. We are all set to embark on the next growth phase with renewed passion."

Strategic Partnership for Expansion

CX Partners is known for investing in healthcare, financial services, consumer products and services, and IT/outsourced services. The firm manages around $1 billion in assets across its funds and co-investors and has a portfolio of approximately 29 companies. 

Prior portfolio companies in healthcare include Natco Pharma, Thyrocare Technologies, and Healthium Medtech. Other investments include Minacs Group (a leading Business Process Outsourcing firm), Sapphire Foods (a leading franchisee of Yum! Brands), Barbeque Nation Hospitality, and Mrs Bectors Food Specialties. 

Sharing insights, Vivek Chhachhi, managing partner of CX Partners, said, "Sabine Hospital and Research Centre provides accessible healthcare at affordable costs. Their world-class fertility treatments cater to people's growing medical needs. While upholding the utmost ethical standards and clinical excellence, the organization has demonstrated remarkable growth, with a CAGR of 25% over the last three years."

Chhachhi also highlighted the potential for further expansion. He mentioned the opportunities to expand Sabine Hospitals to adjacent markets, leveraging their experience in healthcare investments, attracting high-quality professional leadership, and implementing systems to manage growth.

CX Partners' current investments include Veeda Clinical Research, Dindigul Thalapakatti Hotels, Sekhmet Pharma, Ummeed Housing Finance, JJG Aero, Indifi Technologies, and Exotel.

According to the data platform Statista, the hospital market in India is likely to grow at an annual rate of 5.02% from $126.80 billion in revenue in 2024 to $162.00 billion by 2029.